Skip to content
zameds

Thiamine, vitamin b12, vitamin b6

Sold as Neurobion

Combination product

This product contains more than one active ingredient, so it has no single molecular structure.

Background

Loading...
Loading Wikipedia summary

Registration

Applicants
1
Registrations
1

Applicants and registrations

ApplicantBrandsDosagesRegistrationsScheduleLeaflets
Merck (Pty) LtdCertificate held by P&g South African Trading (Pty) LtdNeurobion3 mlH2488Not determinedPIPIL

Variants

ProductStrength and formRegistrationStatusScheduleLeaflets
Neurobion ampoules

EACH AMPOULE CONTAINS THIAMINE HYDROCHLORIDE A 100,0 mg VITAMIN B12 A 1,0 mg VITAMIN B6 A 100,0 mg

3 mlSolution for injectionH2488Approved 7 February 2023Old MedicineNot determinedPIPIL

Regulatory status

This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.

Listings for this ingredient that could not be applied to this product

  • S3: Vitamin b1

    • in preparations thereof for injection; (S0)
    • except in oral preparations or mixtures containing more than 100 mg of Vitamin B1 per recommended daily dose alone or in combination with other active pharmaceutical ingredients. (S1)

    Consolidated Schedules 06 July 2026, lines 4392 to 4397

  • S3: Vitamin b12

    • in preparations thereof for injection; (S0)
    • except in oral preparations or mixtures containing more than 100 µg of Vitamin B12 per recommended daily dose alone or in combination with other active pharmaceutical ingredients. (S1)

    Consolidated Schedules 06 July 2026, lines 4428 to 4433

  • S3: Vitamin b6

    • in preparations thereof for injection; (S0)
    • except in oral preparations or mixtures containing more than 100 mg of Vitamin B6 per recommended daily dose alone or in combination with other active pharmaceutical ingredients. (S1)

    Consolidated Schedules 06 July 2026, lines 4421 to 4426

  • S1: Vitamin b1

    • in oral preparations or mixtures containing more than 100 mg of Vitamin B1 per recommended daily dose alone or in combination with other active pharmaceutical ingredients; (S0)
    • except in preparations thereof for injection. (S3)

    Consolidated Schedules 06 July 2026, lines 1149 to 1154

  • S1: Vitamin b12

    • in oral preparations or mixtures containing more than 100 µg of Vitamin B12 per recommended daily dose alone or in combination with other active pharmaceutical ingredients; (S0)
    • except in preparations thereof for injection. (S3)

    Consolidated Schedules 06 July 2026, lines 1177 to 1182

  • S1: Vitamin b6

    • in oral preparations or mixtures containing more than 100 mg of Vitamin B6 per recommended daily dose alone or in combination with other active pharmaceutical ingredients; (S0)
    • except in preparations thereof for injection. (S3)

    Consolidated Schedules 06 July 2026, lines 1170 to 1175

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

SAHPRA documents

Professional information (PI)For healthcare professionalsNeurobion ampoules, Merck (Pty) LtdPatient information leaflet (PIL)For patients and carersNeurobion ampoules, Merck (Pty) Ltd

These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.

Research articles

Loading...
Loading PubMed articles